Seven out of 10 Americans diagnosed with cancer now survive at least five years. That's a 7-percentage-point jump from the mid-1990s, when the survival rate sat at 63%, according to new data from the American Cancer Society tracking patients diagnosed between 2015 and 2021.
The shift matters most where it's hardest to achieve. Myeloma survival nearly doubled from 32% to 62%. Liver cancer survival more than tripled from 7% to 22%. These aren't marginal improvements in already-treatable cancers — they're dramatic reversals in diagnoses that once meant far grimmer odds.
What's Actually Working
Harold J. Burstein, an oncologist at Dana-Farber Cancer Institute and Harvard Medical School, points to a converging set of breakthroughs. Fewer people are getting lung cancer in the first place, thanks to decades of declining smoking rates. Screening programs have caught colorectal and cervical cancers earlier, when they're more treatable. But the real momentum comes from the drugs themselves.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxImmunotherapy and targeted treatments have reshaped what's possible, especially for advanced disease. CAR-T cell therapy has transformed lymphoma outcomes. Newer breast and head/neck cancer treatments are so effective that surgeons can now do less invasive operations — the drugs do more of the heavy lifting. Personalized, molecular-targeted therapies mean doctors can match treatments to the specific mutations driving each patient's cancer, rather than using one-size-fits-all approaches.
Burstein emphasizes something the raw numbers don't capture: these treatments are also less toxic. Patients aren't just living longer — they're living better during treatment and after.
The progress isn't universal. Pancreatic and brain cancers (glioblastoma) remain stubbornly difficult. But even there, the ability to control advanced disease and extend life with quality intact represents a genuine shift from where oncology stood 30 years ago. Burstein notes that doctors can now often tell patients, "You have an excellent prognosis with treatment" — a sentence that would have been unthinkable for many diagnoses a generation ago.
For the roughly 2 million Americans diagnosed with cancer each year, the data points to a future where early detection and proper treatment increasingly translate into years of life beyond the diagnosis. That's not a cure-all, but it's a measurable change in what's survivable.
